• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Chemed Corp

    3/31/25 3:54:38 PM ET
    $CHE
    Medical/Nursing Services
    Health Care
    Get the next $CHE alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001207137
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    CHEMED CORP
    SEC File Number
    001-08351
    Address of Issuer
    SUITE 2600
    255 E FIFTH ST
    CINCINNATI
    OHIO
    45202
    Phone
    (513)762-6690
    Name of Person for Whose Account the Securities are To Be Sold
    MCNAMARA KEVIN J
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Common
    Merrill Lynch
    5905 E Galbraith Road
    Suite 7000
    Cincinnati � OH � 45236
    1000605700.001463669503/31/2025
    NYSE


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Common03/08/2022Stock AwardKevin J McNamaraCheckbox not checked100003/08/2022Stock Exercise

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Kevin J McNamara
    255 E 5th St
    Suite 2600
    Cincinnati � OH � 45202
    Chemed Corporation03/06/202520001187338.00

    144: Remarks and Signature

    Remarks
    Date of Notice
    03/31/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    Marsha L Conley

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $CHE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHE

    DatePrice TargetRatingAnalyst
    3/4/2022$609.00 → $579.00Outperform
    RBC Capital
    7/29/2021$604.00 → $609.00Outperform
    RBC Capital
    More analyst ratings

    $CHE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

      Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

      5/19/25 2:53:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference

      Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Global Healthcare Conference on Wednesday, May 21, 2025, at approximately 9:30 a.m. (ET) at The InterContinental New York Barclay Hotel in New York City. The audio webcast can be accessed by visiting the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours after the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation's largest provider of

      5/14/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025

      Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Securities 2025 Health Care Conference on Tuesday, May 13, 2025, at 3:40 PM (PDT) at the Encore at the Wynn Las Vegas. The presentation will be webcast live and can be accessed, along with the presentation materials, through the Chemed website at www.chemed.com (Investor Relations). The webcast replay will be available within 24 hours of the live presentation and will be accessible for 90 days. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS i

      5/6/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • VP and Chief Legal Officer Judkins Brian C bought $75,328 worth of Capital Stock (145 units at $519.50), increasing direct ownership by 9% to 1,678 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      12/30/24 11:10:35 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $579.00 from $609.00 previously

      3/4/22 8:31:07 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • RBC Capital reiterated coverage on Chemed with a new price target

      RBC Capital reiterated coverage of Chemed with a rating of Outperform and set a new price target of $609.00 from $604.00 previously

      7/29/21 10:52:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Oppenheimer reiterated coverage on Chemed with a new price target

      Oppenheimer reiterated coverage of Chemed with a rating of Outperform and set a new price target of $580.00 from $600.00 previously

      3/3/21 8:11:56 AM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/13/24 5:01:01 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/23 11:12:43 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Chemed Corp (Amendment)

      SC 13G/A - CHEMED CORP (0000019584) (Subject)

      2/9/22 3:33:36 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Financials

    Live finance-specific insights

    See more
    • Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend

      Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of nine directors at the Company's 2025 annual stockholders' meeting. Stockholders ratified the continuation of PricewaterhouseCoopers LLP as the Company's independent accountants for 2025. Stockholders also approved Chemed's executive compensation and the Company's 2025 Stock Incentive Plan. Dividend Declared Following the stockholders' meeting, Chemed's Board of Directors declared a quarterly cash dividend of 50 cents per share on the Company's capital stock, payable on June 17, 2025, to stockholders of record as of May 29, 2025. This represents the 216th consecutive quarterly dividend paid to stockholders in Chemed's

      5/19/25 2:53:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Reports First-Quarter 2025 Results

      Chemed Corporation (Chemed) (NYSE:CHE), which operates VITAS Healthcare Corporation (VITAS), one of the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its first quarter ended March 31, 2025, versus the comparable prior-year period. Results for Quarter Ended March 31, 2025 Consolidated operating results: Revenue increased 9.8% to $646.9 million GAAP Diluted Earnings-per-Share (EPS) of $4.86, an increase of 14.6% Adjusted Diluted EPS of $5.63, an increase of 8.3% VITAS segment operating results: Net Patient Revenue of $407.4 million, an in

      4/23/25 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24

      Chemed Corporation (NYSE:CHE) today announced that it will release financial results for the first quarter ended March 31, 2025, on Wednesday, April 23, 2025, following the close of trading on the New York Stock Exchange. Chemed will host a conference call and webcast at 10 a.m., ET, on Thursday, April 24, 2025, to discuss the company's quarterly results and to provide an update on its business. Participants may access a live webcast of the conference call through the investor relations section of Chemed's website, Investor Relations Home | Chemed Corporation or the hosting website https://edge.media-server.com/mmc/p/ey8mpmti. Participants may also register via teleconference at: https:/

      4/1/25 12:00:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Walsh George J Iii was granted 277 units of Capital Stock, increasing direct ownership by 9% to 3,323 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:42:26 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Director Mount John Meredith Jr. was granted 277 units of Capital Stock, increasing direct ownership by 42% to 930 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:33:04 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Director Mccarthy Eileen P was granted 277 units of Capital Stock, increasing direct ownership by 48% to 855 units (SEC Form 4)

      4 - CHEMED CORP (0000019584) (Issuer)

      5/20/25 12:28:19 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    Leadership Updates

    Live Leadership Updates

    See more
    • VITAS To Buy Hospice Assets of Covenant Care in Florida and Alabama

      VITAS Healthcare Corporation, a wholly-owned subsidiary of Chemed Corporation ("Chemed") (NYSE:CHE), announced it entered into an agreement on March 12, 2024 to acquire all hospice operations and an assisted living facility from Covenant Health and Community Services, Inc. d/b/a/ Covenant Care ("Covenant") for an aggregate purchase price of $85 million. Covenant's hospice operations span the panhandle of Florida and Alabama, specifically including the Tallahassee, Marianna, Fort Walton Beach, Panama City, Crestview and Pensacola markets in Florida, and the Dothan and Mobile/Daphne markets in Alabama. The transaction is structured as an asset purchase and parties will seek to close the tra

      3/13/24 9:00:00 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Appointment of Michael D. Witzeman as CFO

      Chemed Corporation (NYSE:CHE) – Today Chemed Corporation's Board of Directors has appointed Michael D. Witzeman as Chief Financial Officer, effective January 1, 2024, following the retirement of David P. Williams from that role. Mr. Witzeman is currently Chemed's Vice President and Controller and serves as Chemed's principal accounting officer. He joined Chemed in 2005 following employment as Senior Manager of Assurance at Deloitte & Touche LLP. He is a licensed CPA and a BBA in Accounting from the University of Cincinnati and an MBA from The Ohio State University. Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates t

      12/18/23 1:20:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • Chemed Corporation Announces the Retirement of David P. Williams

      Chemed Corporation (NYSE:CHE) – After more than three decades, Executive Vice President and Chief Financial Officer David P. Williams has announced that he will retire as Chemed's Chief Financial Officer as of December 31, 2023, but Mr. Williams will continue to work with Chemed for the transition period and beyond in providing his guidance and the benefit of his expertise to the executive team and the Board of Directors. Throughout his career, David helped lead Chemed and its subsidiaries through unprecedented economic growth. "It has been a privilege to work with David as an integral part of our management team for these last three decades," said Chemed Chief Executive Officer, Kevin

      11/3/23 4:15:00 PM ET
      $CHE
      Medical/Nursing Services
      Health Care

    $CHE
    SEC Filings

    See more
    • Chemed Corp filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - CHEMED CORP (0000019584) (Filer)

      5/20/25 2:00:14 PM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form S-8 filed by Chemed Corp

      S-8 - CHEMED CORP (0000019584) (Filer)

      5/20/25 10:21:08 AM ET
      $CHE
      Medical/Nursing Services
      Health Care
    • SEC Form 10-Q filed by Chemed Corp

      10-Q - CHEMED CORP (0000019584) (Filer)

      4/28/25 9:06:58 AM ET
      $CHE
      Medical/Nursing Services
      Health Care